Works matching AU Clotet, B.

Results: 93

Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 5, p. 496, doi. 10.1111/jvh.12353

By:

Serrano‐Villar, S.;
Sobrino‐Vegas, P.;
Monge, S.;
Dronda, F.;
Hernando, A.;
Montero, M.;
Viciana, P.;
Clotet, B.;
Pineda, J. A.;
Amo, J.;
Moreno, S.

Publication type:

Article

Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.

Published in:

Journal of Viral Hepatitis, 2014, v. 21, n. 6, p. e19, doi. 10.1111/jvh.12254

By:

Nevot, M.;
Boesecke, C.;
Parera, M.;
Andrés, C.;
Franco, S.;
Revollo, B.;
Ingiliz, P.;
Tural, C.;
Clotet, B.;
Rockstroh, J. K.;
Martinez, M. A.

Publication type:

Article

Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.

Published in:

Journal of Viral Hepatitis, 2011, v. 18, n. 10, p. e578, doi. 10.1111/j.1365-2893.2011.01490.x

By:

Franco, S.;
Bellido, R.;
Aparicio, E.;
Cañete, N.;
García-Retortillo, M.;
Solà, R.;
Tural, C.;
Clotet, B.;
Paredes, R.;
Martínez, M. A.

Publication type:

Article

Hyaluronic acid, transforming growth factor-β1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 7, p. 513, doi. 10.1111/j.1365-2893.2009.01103.x

By:

Sanvisens, A.;
Serra, I.;
Tural, C.;
Tor, J.;
Ojanguren, I.;
Barluenga, E.;
Rey-Joly, C.;
Clotet, B.;
Muga, R.

Publication type:

Article

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.

Published in:

Journal of Viral Hepatitis, 2007, v. 14, n. 10, p. 704, doi. 10.1111/j.1365-2893.2007.00860.x

By:

Tural, C.;
Solà, R.;
Rubio, R.;
Santín, M.;
Planas, R.;
Quereda, C.;
Berenguer, J.;
Montes-Ramírez, M.;
Clotet, B.

Publication type:

Article

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.

Published in:

Journal of Viral Hepatitis, 2003, v. 10, n. 2, p. 118, doi. 10.1046/j.1365-2893.2003.00413.x

By:

Tural, C.;
Fuster, D.;
Tor, J.;
Ojanguren, I.;
Sirera, G.;
Ballesteros, À.;
Lasanta, J. A. J.;
Planas, R.;
Rey-Joly, C.;
Clotet, B.

Publication type:

Article

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

Published in:

1998

By:

Hirsch MS;
Conway B;
D'Aquila RT;
Johnson VA;
Brun-Vézinet F;
Clotet B;
Demeter LM;
Hammer SM;
Jacobsen DM;
Kuritzkes DR;
Loveday C;
Mellors JW;
Vella S;
Richman DD;
International AIDS Society-USA Panel;
Hirsch, M S;
Conway, B;
D'Aquila, R T;
Johnson, V A;
Brun-Vézinet, F

Publication type:

journal article

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

Published in:

HIV Medicine, 2019, v. 20, n. 3, p. 230, doi. 10.1111/hiv.12705

By:

Malin, JJ;
Boesecke, C;
Schwarze‐Zander, C;
Wasmuth, JC;
Schlabe, S;
Trebicka, J;
Spengler, U;
Llibre, JM;
Jou, T;
Vasylyev, M;
Clotet, B;
Rockstroh, JK

Publication type:

Article

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.

Published in:

HIV Medicine, 2018, v. 19, n. 4, p. 252, doi. 10.1111/hiv.12573

By:

Roen, A.;
Laut, K.;
Pelchen‐Matthews, A.;
Borodulina, E.;
Caldeira, L.;
Clarke, A.;
Clotet, B.;
d'Arminio Monforte, A.;
Fätkenheuer, G.;
Gatell Artigas, J. M.;
Karpov, I.;
Kuznetsova, A.;
Kyselyova, G.;
Mozer‐Lisewska, I.;
Mulcahy, F.;
Ragone, L.;
Scherrer, A.;
Uzdaviniene, V.;
Vandekerckhove, L.;
Vannappagari, V.

Publication type:

Article

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.

Published in:

HIV Medicine, 2017, v. 18, n. 10, p. 782, doi. 10.1111/hiv.12530

By:

Echeverría, P;
Bonjoch, A;
Puig, J;
Ornella, A;
Clotet, B;
Negredo, E

Publication type:

Article

Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-up.

Published in:

HIV Medicine, 2016, v. 17, n. 6, p. 479, doi. 10.1111/hiv.12361

By:

Videla, S;
Sirera, G;
Ornelas, A;
Piñol, M;
García‐Cuyás, F;
Llatjos, M;
Castellá, E;
Coll, J;
Segundo, C;
Clotet, B

Publication type:

Article

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.

Published in:

HIV Medicine, 2015, v. 16, n. 10, p. 628, doi. 10.1111/hiv.12298

By:

Pedrol, E;
Llibre, JM;
Tasias, M;
Currán, A;
Guardiola, JM;
Deig, E;
Guelar, A;
Martínez‐Madrid, O;
Tikhomirova, L;
Ramírez, R;
Pedrol, E.;
Tasias, M.;
Ramírez, R.;
Tikhomirova, L.;
Ruiz, S.;
Delegido, A.;
Clotet, B.;
Llibre, J. M.;
Curran, A.;
Guardiola, J. M.

Publication type:

Article

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years.

Published in:

HIV Medicine, 2015, v. 16, n. 7, p. 441, doi. 10.1111/hiv.12260

By:

Negredo, E;
Bonjoch, A;
Pérez‐Álvarez, N;
Ornelas, A;
Puig, J;
Herrero, C;
Estany, C;
Río, L;
Gregorio, S;
Echeverría, P;
Clotet, B

Publication type:

Article

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 370, doi. 10.1111/hiv.12210

By:

Martínez, E;
Ribera, E;
Clotet, B;
Estrada, V;
Sanz, J;
Berenguer, J;
Rubio, R;
Pulido, F;
Larrousse, M;
Curran, A;
Negredo, E;
Arterburn, S;
Ferrer, P;
Álvarez, ML

Publication type:

Article

Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.

Published in:

HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218

By:

Vingerhoets, J;
Calvez, V;
Flandre, P;
Marcelin, A‐G;
Ceccherini‐Silberstein, F;
Perno, C‐F;
Mercedes Santoro, M;
Bateson, R;
Nelson, M;
Cozzi‐Lepri, A;
Grarup, J;
Lundgren, J;
Incardona, F;
Kaiser, R;
Sonnerborg, A;
Clotet, B;
Paredes, R;
Günthard, HF;
Ledergerber, B;
Hoogstoel, A

Publication type:

Article

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

Published in:

HIV Medicine, 2014, v. 15, n. 4, p. 203, doi. 10.1111/hiv.12105

By:

Sanmartín, R;
Tor, J;
Sanvisens, A;
López, JJ;
Jou, A;
Muga, R;
Ojanguren, I;
Barluenga, E;
Videla, S;
Planas, R;
Clotet, B;
Tural, C

Publication type:

Article

Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve...

Published in:

2013

By:

Mills, Am;
Antinori, A;
Clotet, B;
Fourie, J;
Herrera, G;
Hicks, C;
Madruga, Jv;
Vanveggel, S;
Stevens, M;
Boven, K

Publication type:

Journal Article

Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks

Published in:

HIV Medicine, 2013, v. 14, n. 7, p. 391, doi. 10.1111/hiv.12012

By:

Mills, AM;
Antinori, A;
Clotet, B;
Fourie, J;
Herrera, G;
Hicks, C;
Madruga, JV;
Vanveggel, S;
Stevens, M;
Boven, K

Publication type:

Article

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

Published in:

HIV Medicine, 2013, v. 14, n. 6, p. 327, doi. 10.1111/hiv.12011

By:

Ribera, E;
Larrousse, M;
Curran, A;
Negredo, E;
Clotet, B;
Estrada, V;
Sanz, J;
Berenguer, J;
Rubio, R;
Pulido, F;
Ferrer, P;
Alvarez, ML;
Arterburn, S;
Martínez, E

Publication type:

Article

Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected men.

Published in:

HIV Medicine, 2012, v. 13, n. 9, p. 549, doi. 10.1111/j.1468-1293.2012.01013.x

By:

Darwich, L;
Cañadas, Mp;
Videla, S;
Coll, J;
Piñol, M;
Cobarsi, P;
Molina-López, Ra;
Vela, S;
García-Cuyás, F;
Llatjos, M;
Sirera, G;
Clotet, B;
Fernández, I.;
Castella, E.;
Llatjós, M.;
Bonjoch, A.;
Echevarría, P.;
Jabaloyas, M.;
Jou, A.;
Llibre, J. M.

Publication type:

Article

The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI.

Published in:

HIV Medicine, 2012, v. 13, n. 1, p. 62, doi. 10.1111/j.1468-1293.2011.00943.x

By:

Cozzi-Lepri, A;
Paredes, R;
Phillips, AN;
Clotet, B;
Kjær, J;
Von Wyl, V;
Kronborg, G;
Castagna, A;
Bogner, JR;
Lundgren, JD

Publication type:

Article

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

Published in:

2011

By:

Podzamczer, D.;
Andrade-Villanueva, J.;
Clotet, B.;
Taylor, S.;
Rockstroh, J. K.;
Reiss, P.;
Domingo, P.;
Gellermann, H. J.;
de Rossi, L.;
Cairns, V.;
Soriano, V.

Publication type:

Journal Article

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).

Published in:

HIV Medicine, 2011, v. 12, n. 6, p. 374, doi. 10.1111/j.1468-1293.2011.00917.x

By:

Podzamczer, D.;
Andrade-Villanueva, J.;
Clotet, B.;
Taylor, S.;
Rockstroh, J. K.;
Reiss, P.;
Domingo, P.;
Gellermann, H. J.;
de Rossi, L.;
Cairns, V.;
Soriano, V.

Publication type:

Article

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 469, doi. 10.1111/j.1468-1293.2009.00816.x

By:

Reekie, J.;
Mocroft, A.;
Ledergerber, B.;
Beniowski, M.;
Clotet, B.;
van Lunzen, J.;
Chiesi, A.;
Pradier, C.;
Machala, L.;
Lundgren, J. D.

Publication type:

Article

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study [corrected] [published erratum appears in HIV MED 2009 Jul;10(6):376].

Published in:

2008

By:

Llibre JM;
Bonjoch A;
Iribarren J;
Galindo MJ;
Negredo E;
Domingo P;
Pérez-Alvarez N;
Martinez-Picado J;
Schapiro J;
Clotet B;
HIV Conference Call study group

Publication type:

Journal Article

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

Published in:

HIV Medicine, 2008, v. 9, n. 7, p. 508, doi. 10.1111/j.1468-1293.2008.00581.x

By:

Llibre, JM;
Bonjoch, A;
Iribarren, J;
Galindo, MJ;
Negredo, E;
Domingo, P;
Pérez-Alvarez, N;
Martinez-Picado, J;
Schapiro, J;
Clotet, B

Publication type:

Article

Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts.

Published in:

HIV Medicine, 2008, v. 9, n. 4, p. 221, doi. 10.1111/j.1468-1293.2008.00552.x

By:

De Lazzari, E.;
León, A.;
Arnaiz, J. A.;
Martinez, E.;
Knobel, H.;
Negredo, E.;
Clotet, B.;
Montaner, J.;
Storfer, S.;
Asenjo, M. A.;
Mallolas, J.;
Mir, J. M.;
Gatell, J. M.

Publication type:

Article

Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999.

Published in:

HIV Medicine, 2008, v. 9, n. 1, p. 41, doi. 10.1111/j.1468-1293.2008.00519.x

By:

Mocroft, A.;
Horban, A.;
Clotet, B.;
d'Arminio Monforte, A.;
Bogner, J. R.;
Aldins, P.;
Staub, T.;
Antunes, F.;
Katlama, C.;
Lundgren, J. D.

Publication type:

Article

Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavir.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 67, doi. 10.1111/j.1468-1293.2006.00351.x

By:

Hill, A.;
Walmsley, S.;
Clotet, B.;
Molto, J.

Publication type:

Article

Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 107, doi. 10.1111/j.1468-1293.2005.00272.x

By:

Johnson, M.;
Nieto-Cisneros, L.;
Horban, A.;
Arasteh, K.;
Gonzalez-Garcia, J.;
Artigas, J. G.;
Clotet, B.;
Danise, A.;
Landman, R.;
Proll, S.;
Snowden, W.;
Foreman, R.;
Smith, P.

Publication type:

Article

Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trial.

Published in:

HIV Medicine, 2001, v. 2, n. 1, p. 27

By:

Katlama, C.;
Clotet, B.;
Plettenberg, A.;
Jost, J.;
Arasteh, K.;
Bernasconi, E.;
Jeantils, V.;
Cutrell, A.;
Stone, C.;
Purdon, S.

Publication type:

Article

Induction of interleukins IL-6 and IL-8 by siRNA.

Published in:

Clinical & Experimental Immunology, 2007, v. 147, n. 1, p. 189, doi. 10.1111/j.1365-2249.2006.03263.x

By:

Pauls, E.;
Senserrich, J.;
Bofill, M.;
Clotet, B.;
Esté, J. A.

Publication type:

Article

Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.

Published in:

Clinical & Experimental Immunology, 2006, v. 145, n. 3, p. 535, doi. 10.1111/j.1365-2249.2006.03145.x

By:

Coma, G.;
Peña, R.;
Blanco, J.;
Rosell, A.;
Borras, F. E.;
Esté, J. A.;
Clotet, B.;
Ruiz, L.;
Parkhouse, R. M. E.;
Bofill, M.

Publication type:

Article

Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA<sup>+</sup> and CD45RO<sup>+</sup> phenotype from tonsils, cord and adult peripheral blood.

Published in:

Clinical & Experimental Immunology, 2004, v. 138, n. 3, p. 460, doi. 10.1111/j.1365-2249.2004.02651.x

By:

Bofill, M.;
Almirall, E.;
McQuaid, A.;
Peña, R.;
Ruiz-Hernandez, R.;
Naranjo, M.;
Ruiz, L.;
Clotet, B.

Publication type:

Article

Our experience with negative images of bacilli in Fine-Needle Aspiration Biopsies (FNAB) from lymph nodes of patients with Acquired Immunodeficiency Syndrome (AIDS).

Published in:

Diagnostic Cytopathology, 1994, v. 10, n. 2, p. 196, doi. 10.1002/dc.2840100224

By:

Urban, A.;
Llatjós, M.;
Romeu, J.;
Martinez-Ortega, S.;
Clotet, B.

Publication type:

Article

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.

Published in:

2009

By:

Moltó J;
Llibre JM;
Ribera E;
Mínguez C;
del Río JS;
Pedrol E;
Vallecillo G;
Cedeño S;
Valle M;
Miranda C;
Negredo E;
Clotet B

Publication type:

Journal Article

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 464

By:

R. López-Vélez;
F. Laguna;
J. Alvar;
S. Videla;
M.E. Jiménez-Mejías;
G. Sirera;
J. Torre-Cisneros;
E. Ribera;
D. Prados;
B. Clotet;
M. Sust

Publication type:

Article

Plasmapheresis in Felty's syndrome.

Published in:

1985

By:

Clotet, B.;
Argelagués, E.;
Junc, J.;
Grifol, M.;
Sanz, J.;
Ribera, A.;
Lience, E.;
Foz, M.;
Argelagués, E;
Juncà, J

Publication type:

Letter

Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis.

Published in:

1984

By:

Clotet, B.;
Guardia, J.;
Pigrau, C.;
Lience, E.;
Murcia, C.;
Pujol, R.;
Bacard, R.;
Bacardí, R

Publication type:

journal article

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.

Published in:

AIDS Care, 2007, v. 19, n. 1, p. 138, doi. 10.1080/09540120600645539

By:

Fumaz, C. R.;
Muñoz-Moreno, J. A.;
Ballesteros, A. L.;
Paredes, R.;
Ferrer, M. J.;
Salas, A.;
Fuster, D.;
Masmitjà, E.;
Pérez-Álvarez, N.;
Gómez, G.;
Tural, C.;
Clotet, B.

Publication type:

Article

Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders.

Published in:

2009

By:

Fumaz CR;
Muñoz-Moreno JA;
Ferrer MJ;
Negredo E;
Pérez-Alvarez N;
Tarrats A;
Clotet B

Publication type:

Journal Article

Immunologic response to protease inhibitor-based highly active antiretroviral therapy: a review.

Published in:

2007

By:

Wainberg MA;
Clotet B

Publication type:

Journal Article

HIV-2 in Spanish Drug Abusers.

Published in:

Vox Sanguinis, 1989, v. 57, n. 2, p. 157, doi. 10.1111/j.1423-0410.1989.tb01157.x

By:

Sorianoa, V.;
Tor, J.;
Ribera, A.;
Clotet, B.;
Martin, J.;
Foz, M.

Publication type:

Article

MULTILOBATED NUCLEI IN PERIPHERAL BLOOD LYMPHOCYTES FROM HIV+ PATIENTS.

Published in:

British Journal of Haematology, 1989, v. 73, n. 2, p. 275, doi. 10.1111/j.1365-2141.1989.tb00268.x

By:

Juncà, J.;
Clotet, B.;
Millà, F.

Publication type:

Article

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

Published in:

2008

By:

Moltó J;
Barbanoj MJ;
Miranda C;
Blanco A;
Santos JR;
Negredo E;
Costa J;
Domingo P;
Clotet B;
Valle M;
Moltó, José;
Barbanoj, Manuel José;
Miranda, Cristina;
Blanco, Asunción;
Santos, José Ramón;
Negredo, Eugenia;
Costa, Joan;
Domingo, Pere;
Clotet, Bonaventura;
Valle, Marta

Publication type:

journal article

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

Published in:

AIDS Care, 2008, v. 20, n. 7, p. 796, doi. 10.1080/09540120701694022

By:

Fumaz, C.R.;
Muñoz-Moreno, J.A.;
Moltó, J.;
Ferrer, M.J.;
López-Blázquez, R.;
Negredo, E.;
Paredes, R.;
Gómez, G.;
Clotet, B.

Publication type:

Article

Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives.

Published in:

2000

By:

Barretina, J.;
Blanco, J.;
Gutierrez, A.;
Puig, L.;
Altisent, C.;
Espanol, T.;
Caragol, I.;
Clotet, B.;
Este, J.A.;
Gutiérrez, A;
Esté, J A

Publication type:

journal article

Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS)

Published in:

1989

By:

Condom, M J;
Clotet, B;
Sirera, G;
Milla, F;
Foz, M

Publication type:

Case Study

CAMBIOS ANTROPOMÉTRICOS EN PACIENTES COINFECTADOS POR VIH/VHC EN TRATAMIENTO CON INTERFERÓN PEGILADO Y RIBAVIRINA Y QUE INTERRUMPEN ANTIRRETROVIRALES.

Published in:

Nutrición Hospitalaria, 2007, v. 22, p. 75

By:

C., Estany;
E., Martínez-López;
R., López-Blázquez;
C., Tural;
A., Salas;
A., Cantón;
A., Sanmartí;
B., Clotet

Publication type:

Article

CAMBIOS ANTROPOMÉTRICOS EN PACIENTES COINFECTADOS POR VIH-VHC QUE REALIZAN TRATAMIENTO DE INDUCCIÓN CON INTERFERÓN Y RIBAVIRINA.

Published in:

Nutrición Hospitalaria, 2007, v. 22, p. 71

By:

C., Estany;
E., Martínez-López;
R., López-Blázquez;
C., Tural;
A., Salas;
A., Cantón;
A., Sanmartí;
B., Clotet

Publication type:

Article